{"id":"W2468990687","doi":"10.1200/jco.2013.31.15_suppl.tps7129","title":"EPIC: A phase III randomized, open-label study of ponatinib versus imatinib in adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ponatinib; Medicine; Imatinib; Myeloid leukemia; Internal medicine; Oncology; Imatinib mesylate; Tyrosine-kinase inhibitor; Nilotinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002202541,0.001991297,0.002868154,0.0004274796,0.0004493152,0.00103547,0.001201896,0.001698935,0.008183327],"category_scores_gemma":[0.001846955,0.0006776849,0.0013802,0.0004936535,0.001183252,0.001577728,0.0006084591,0.003057616,0.001223671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008064658,"about_ca_system_score_gemma":0.001596809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008073785,"about_ca_topic_score_gemma":0.002584271,"domain_scores_codex":[0.9993137,0.0003681999,0.00003587261,0.0001049228,0.00005206448,0.0001252612],"domain_scores_gemma":[0.9989395,0.0002062325,0.0002161346,0.00006796794,0.00007846201,0.0004917294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9617572,0.01282954,0.001343438,0.0005432013,0.0006995701,0.00005814456,0.00007078626,0.0005182824,0.002481192,0.0001953308,0.001620685,0.01788267],"study_design_scores_gemma":[0.9263769,0.06954993,0.002181775,0.00001663807,0.0001842208,0.00005032681,0.00002230665,0.0003147223,0.0001649802,0.0001558168,0.0009711897,0.00001123692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9748918,0.004005844,0.001034581,0.001039862,0.0005270325,0.01199003,0.002699315,0.0001918624,0.003619515],"genre_scores_gemma":[0.9687809,0.003130255,0.003275395,0.002879875,0.0004516658,0.01314647,0.003233739,0.00004115756,0.005060583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008183327,"threshold_uncertainty_score":0.027376,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07600175076412469,"score_gpt":0.4454941115385204,"score_spread":0.3694923607743957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}